Shares of Quoin Pharmaceuticals rose after the company succeeded in formulating two of its drug delivery technologies at target loading concentrations. The stock climbed 24% to $10.10 Tuesday. Shares ...

Ivor Campbell, CEO of medtech recruitment consultancy Snedden Campbell, reflects on what companies in the UK and Europe can do to compete for investment against the US.

Investing.com -- Quoin Pharmaceuticals Ltd (NASDAQ:QNRX) stock surged 66% in premarket trading Tuesday after the company announced it has successfully achieved target loading concentrations for its ...

The fast development of the city has led to more traffic and construction areas, not to mention increasing working place ...

Dr. Lacey Anderson explains how different medications help control high blood pressure and shares details on a new Tecton ...

The global Wastewater Surveillance Market, valued at US$0.82 billion in 2024, stood at US$0.88 billion in 2025 and is ...

Over the course of the patient's treatment, there were opportunities to recognize the error and prevent the patient's catastrophic results.

At the beginning of the quarter, Virtus liquidated its position in Novo Nordisk (NVO) and used the proceeds to fund a new ...

Alibaba was a contributor to the portfolio during the quarter, driven by strong execution in its core commerce and cloud ...